http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 08 Aug 2024 06:03:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html si-local-file:///var/storage/secattach/20240808/23568944.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html Thu, 08 Aug 2024 06:03:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html si-local-file:///var/storage/secattach/20240808/23568944.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html Thu, 08 Aug 2024 06:03:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html si-local-file:///var/storage/secattach/20240808/23568944.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Aug+07/23568944.html Thu, 08 Aug 2024 06:03:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Corporate+News/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html <p><span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p><p>"<span value="NYSE:LH" idsrc="xmltag.org">Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org">Invitae</span> are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said <person>Mark Schroeder</person>, Executive Vice President and President of <span>Diagnostics http://www.streetinsider.com/Mergers+and+Acquisitions/Labcorp+%28LH%29+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549191.html Mon, 05 Aug 2024 07:02:00 -0400 LH NVTA NVTAQ http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/Press+Releases/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html <div class="xn-content"> <p class="prntac"><b><i>Extends Labcorp's leadership in genetic testing solutions for oncology and select rare diseases</i></b></p> <p><span class="legendSpanClass"><location value="LU/us.nc.burltn" idsrc="xmltag.org" >BURLINGTON, N.C.</location></span>, <span class="legendSpanClass"><chron>Aug. 5, 2024</chron></span> /PRNewswire/ -- <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> (OTC:NVTAQ), a leading medical genetics company. Together, <span value="NYSE:LH" idsrc="xmltag.org" >Labcorp</span> and <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span> will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> http://www.streetinsider.com/PRNewswire/Labcorp+Finalizes+Acquisition+of+Select+Assets+of+Invitae/23549152.html Mon, 05 Aug 2024 07:00:00 -0400 LH NVTA NVTAQ O.00178988 O.08322671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html si-local-file:///var/storage/secattach/20240731/23527736.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html Wed, 31 Jul 2024 06:02:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html si-local-file:///var/storage/secattach/20240731/23527736.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html Wed, 31 Jul 2024 06:02:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html si-local-file:///var/storage/secattach/20240731/23527736.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Invitae+Corp++++++++++++++For%3A+Jul+30/23527736.html Wed, 31 Jul 2024 06:02:00 -0400 NVTA NVTAQ O.08322671 http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html <div class="xn-content"> <p class="prntac">– Program provides accessible and affordable testing for pediatric epilepsy patients –</p> <p class="prntac">– Genetic and clinical insights from test results to strengthen <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae's</span> rare disease database –</p> <p><span class="legendSpanClass"><location value="LU/us.ca.sanfrn" idsrc="xmltag.org" >SAN FRANCISCO</location></span>, <span class="legendSpanClass">July 22, 2024 </span> /PRNewswire/ -- <u><a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4215624-1&amp;h=908765425&amp;u=https%3A%2F%2Fwww.invitae.com%2F&amp;a=Invitae" target="_blank" rel="nofollow"><span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span></a></u> (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure^®program, which provides accessible and affordable genetic testing for pediatric epilepsy patients in the hopes of shortening the diagnostic odyssey and enabling a path towards effective, personalized care and precision therapy¹.</p> http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html Mon, 22 Jul 2024 07:30:00 -0400 A.09642568 NVTAQ O.08322671 O.20371933 http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html <div class="xn-content"> <p class="prntac">– Program provides accessible and affordable testing for pediatric epilepsy patients –</p> <p class="prntac">– Genetic and clinical insights from test results to strengthen <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae's</span> rare disease database –</p> <p><span class="legendSpanClass"><location value="LU/us.ca.sanfrn" idsrc="xmltag.org" >SAN FRANCISCO</location></span>, <span class="legendSpanClass">July 22, 2024 </span> /PRNewswire/ -- <u><a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4215624-1&amp;h=908765425&amp;u=https%3A%2F%2Fwww.invitae.com%2F&amp;a=Invitae" target="_blank" rel="nofollow"><span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span></a></u> (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure^®program, which provides accessible and affordable genetic testing for pediatric epilepsy patients in the hopes of shortening the diagnostic odyssey and enabling a path towards effective, personalized care and precision therapy¹.</p> http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html Mon, 22 Jul 2024 07:30:00 -0400 A.09642568 NVTAQ O.08322671 O.20371933 http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html <div class="xn-content"> <p class="prntac">– Program provides accessible and affordable testing for pediatric epilepsy patients –</p> <p class="prntac">– Genetic and clinical insights from test results to strengthen <span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae's</span> rare disease database –</p> <p><span class="legendSpanClass"><location value="LU/us.ca.sanfrn" idsrc="xmltag.org" >SAN FRANCISCO</location></span>, <span class="legendSpanClass">July 22, 2024 </span> /PRNewswire/ -- <u><a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4215624-1&amp;h=908765425&amp;u=https%3A%2F%2Fwww.invitae.com%2F&amp;a=Invitae" target="_blank" rel="nofollow"><span value="OTC-PINK:NVTAQ" idsrc="xmltag.org" >Invitae</span></a></u> (OTC: NVTAQ), a leading medical genetics company, today announced the launch of its Unlock™ Behind the Seizure^®program, which provides accessible and affordable genetic testing for pediatric epilepsy patients in the hopes of shortening the diagnostic odyssey and enabling a path towards effective, personalized care and precision therapy¹.</p> http://www.streetinsider.com/Press+Releases/Invitae+Launches+Unlock%E2%84%A2+Behind+the+Seizure%C2%AE+Program+for+Pediatric+Epilepsy+Patients/23486200.html Mon, 22 Jul 2024 07:30:00 -0400 A.09642568 NVTAQ O.08322671 O.20371933